期刊文献+

规制权利配置、均衡影响与社会性规制体系完善 被引量:3

Configuration of Regulation Rights,Equilibrium Effect and Improvement of Social Regulation
下载PDF
导出
摘要 许多研究表明,社会性规制失效已不是简单的投入不足问题,其背后蕴藏的深刻动因值得我们探析,本文从规制权利的纵向配置出发,对Fredriksson&Gaston(2000)模型进行调整,分析并比较了规制集权与规制分权的均衡结果,并结合中国社会性规制现实分析造成社会性规制失效的可能动因。研究表明,在一定假设下,规制集权与分权都可以达到最优的均衡。结合中国社会性规制体制制度特征,本文认为,调整地方政府的目标函数及其行为,畅通公众偏好表达渠道是提高规制决策与实施效果的重要因素。在此基础上,给出了中国社会性规制体系完善的初步设想。 As many studies have shown, loss of effectiveness of social regulation is not merely a problem of under-invest-ment any more.The real reason for it is worth exploring.This article begins at the longitudinal configuration of regulation rights.With an adjusted model of Fredriksson & Gaston (2000), it analyzes and compares the resulting effects of centraliza-tion and decentralization of regulation rights.The study shows that both centralization and decentralization practices can a-chieve optimal equilibrium under certain assumptions.Considering China's reality, this paper argues that revising the objective function of local governments and smoothing the channels for expressing public preferences are important steps to improve the effects of regulatory decision-making and implementation.It provides some basic thoughts on the reconstruction of Chinese so-cial regulation system.
作者 韩超
出处 《财经论丛》 CSSCI 北大核心 2014年第10期84-92,共9页 Collected Essays on Finance and Economics
基金 国家自然科学基金资助项目(71303034) 辽宁省社会科学规划基金资助项目(L13DJL029) 东北财经大学优秀人才创新项目(DUFE2014R02)
关键词 规制分权 规制集权 规制重构 regulation centralization regulation decentralization regulation reconstruction
  • 相关文献

二级参考文献135

共引文献7745

同被引文献64

  • 1刘华军.论政府规制均衡及均衡的动态调整[J].财贸研究,2004,15(4):7-10. 被引量:6
  • 2植草益.微观规制经济学[M].北京:中国发展出版社,1992..
  • 3樊纲.中国经济的风险在于制度性缺陷[J].改革与开放,2007(12):4-6. 被引量:2
  • 4Blind, Knut. The Influence of Regulations on Innovation, A Quantitative Assessment for OECD Countries[J]. Research Policy ,2012, 41,(2) :391-400.
  • 5Day, K. A., Frisvold, G. B. Medical research and genetic resources management: The ease of Taxol[J]. Contemporary Policy Issues. 1993,(11): 1-11.
  • 6Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski. The price of innovation: new estimates of drug development costs[J]. Journal of Health Economics. 2003,(22) : 151-185.
  • 7William W. MeCutchen, Jr. Estimating the impact of the R&D tax credit on strategic groups in the pharmaceutieal industry[J]. Research Policy. 1993,22,(4) : 337-351.
  • 8Katia De Pinho Campos, Cameron D. Norman, Alejandro R. Jadad. Produet development public-private partnerships for public health: A systematic review using qualitative data. Social Science & Medicine[J]. 2011,(73 ) :986-994.
  • 9Katz, A. Pharmaeeutieal Lemons: Innovation and Regulation in the Drug Industry[J]. Miehigan Telecommunications and Teehnology Law Review. 2007, ( 1 ) : 1-41.
  • 10Gastineau, D. A. Will Regulation Be the Death of Cell Therapy in the United States [J] . Bone Marrow Transplantation. 2004, (8) : 777- 780.

引证文献3

二级引证文献214

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部